Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caspofungin vs Liposomal Amphotericin B for Febrile Neutropenia
NCT00008359Phase 3Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2000
- Primary completion
- Mar 2003
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of caspofungin in febrile neutropenia (FN), sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 2000; status: completed.
02
Drugs
caspofungin
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT00008359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00008359.